BIOIBERICA

The quality controls at Bioibérica have always aimed to improve the standard requirements in its various markets.Constant innovation in the control methods used in our laboratories (infrared, electrophoresis, spectrophotometry, mass spectrophotometry, chromatography, potentiometry, magnetic resonance, LAL, coagulometry, polarimetry, HPLC, etc.) and our highly qualified technicians, allow us to talk about distinctive quality in all processes and all products at Bioibérica.All our suppliers are also required to comply with these quality standards by means of international audits of raw materials and permanent microbiological monitoring.

Contact Details: Pl. Francesc Macià, 7 Barcelona 08029 Spain Tel: 34 93 490 49 08 Fax: 34 93 490 97 11 Email: info@bioiberica.com WWW: www.BIOIBERICA.COM/

Recent Publications by BIOIBERICA:
Clinical and histopathological improvement of psoriasis with oral chondroitin sulfate: a serendipitous finding. We describe the clinical and histopathological results of plaque psoriasis...	21st June, 2006	Clinical Research Unit, Scientific Medical Department, Bioiberica, S.A.,	Dermatol Online J. 2005 Mar 1;11(1):31.
Cell therapy: a therapeutic alternative to treat focal cartilage lesions. BACKGROUND: Human mesenchymal stem cells (MSCs) are present in most of the...	16th February, 2006	Unidad de Investigacion del Envejecimiento Osteoarticular and Catedra	Transplant Proc. 2005 Nov;37(9):4080-3. DOI Direct Link
[Clinical and histopathological improvement of psoriasis in patients with osteoarthritis treated with chondroitin sulfate: report of 3 cases] BACKGROUND AND OBJECTIVE: After prescribing chrondroitin sulfate for the...	2nd March, 2005	Unidad de Investigacion Clinica, Departamento Medico y Cientifico,	Med Clin (Barc). 2004 Nov 27;123(19):739-42.
Weather conditions can influence rheumatic diseases. In daily clinical practice, many patients attribute joint pain to weather...	27th January, 2005	Scientific Medical Department, Bioiberica Farma, Plaza Francesc Macia 7,	Proc West Pharmacol Soc. 2004;47:134-6.
On the bioavailability of oral chondroitin sulfate formulations: proposed criteria for bioequivalence studies. Chondroitin sulfate (CS) is a symptomatic slow-acting drug for...	27th January, 2005	Bioiberica, Scientific Medical Department, Plaza Francesc Macia 7, 08029	Proc West Pharmacol Soc. 2004;47:50-3.
→View more BIOIBERICA research publications.

BIOIBERICA Clinical Trials:
Chondroitin Sulphate Efficay/Safety in Patients With Knee Osteoarthritis and Psoriasis

BIOIBERICA Patents:
US Patent No.	Title
7141556	Process for the preparation of glucosamine salts
6680304	Disaccharides with anti-arthrosic properties
5084564	Production of oligosaccharide fractions having antithrombotic properties by controlled chemical depolymerization of heparin

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 708 times since April 2007, the link to the organisation's website has been followed 97 times

Recent Search Terms used to find this page: bioberica e-mail | bioiberica | bioiberica heparin | bioiberica | BIOIBERICA | bioiberica | bioiberica | bioiberica | bioiberica | bioiberica | .

Search for more companies in Barcelona

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for BIOIBERICA